4SCAR7U
/ SZGIMI
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
August 27, 2026
Universal 4SCAR7U Targeting CD7-positive Malignancies
(clinicaltrials.gov)
- P1 | N=30 | Not yet recruiting | Sponsor: Shenzhen Geno-Immune Medical Institute | Trial completion date: Dec 2026 ➔ Dec 2028 | Trial primary completion date: Sep 2026 ➔ Jul 2028
Trial completion date • Trial primary completion date • Acute Lymphocytic Leukemia • Acute Myelogenous Leukemia • Hematological Malignancies • Leukemia • Lymphoma • Oncology • T Acute Lymphoblastic Leukemia • T-cell Acute Lymphoblastic Lymphoma • CD7
August 16, 2023
Universal 4SCAR7U Targeting CD7-positive Malignancies
(clinicaltrials.gov)
- P1 | N=30 | Recruiting | Sponsor: Shenzhen Geno-Immune Medical Institute
New P1 trial • Acute Lymphocytic Leukemia • Acute Myelogenous Leukemia • Hematological Disorders • Hematological Malignancies • Leukemia • Lymphoma • Oncology • T Acute Lymphoblastic Leukemia • CD7
1 to 2
Of
2
Go to page
1